- Home
- OCUL vs PTY Comparison
OCUL vs PTY Comparison
Compare OCUL & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCUL | PTY |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | OCUL | PTY |
|---|---|---|
| Price | $9.11 | $13.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.56 | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 550.4K |
| Earning Date | 02-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,951,000.00 | N/A |
| Revenue This Year | $20.43 | N/A |
| Revenue Next Year | $79.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.79 | $11.92 |
| 52 Week High | $16.44 | $14.88 |
Technical Indicators
Market Signals| Indicator | OCUL | PTY |
|---|---|---|
| Relative Strength Index (RSI) | 36.76 | 56.48 |
| Support Level | $8.36 | $12.98 |
| Resistance Level | $9.69 | $13.11 |
| Average True Range (ATR) | 0.67 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 27.37 | 75.83 |
Price Performance
Historical ComparisonAbout OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About PTY Pimco Corporate & Income Opportunity Fund
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.